← Leaderboards
Apar Kishor Ganti
University Of Nebraska Medical Center
$2,107,625
Attributed
$2,107,625
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $269.8K · FY2016–25$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,107,625 · 6
VA$0 · 1
By mechanism
P30$2,107,625 · 6
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- John David Dickinson$3,503,821
- Maneesh Jain$6,905,007
- Mohd Wasim Nasser$4,858,883
- Pi-Wan Cheng$3,131,854
- Kenneth Cowan$25,385,222
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsNebraskaAmendmentSiteScreeningSafetyClinical ResearchEnrollmentProtocols DocumentationPopulation SciencesCancer Center Support GrantRegulationResearch PersonnelReview CommitteeCancer CenterCancer TherapyClinical TrialsCaringMonitorMemberEnsureReportingMedical CenterUniversities
Grant awards (24)
Clinical Protocol and Data Management$144,638
P30 · FY2025 · CA · contact PI
Protocol Review and Monitoring System$125,120
P30 · FY2025 · CA · contact PI
Clinical Protocol and Data Management$133,939
P30 · FY2024 · CA · contact PI
Protocol Review and Monitoring System$115,865
P30 · FY2024 · CA · contact PI
Clinical Protocol and Data Management$133,938
P30 · FY2023 · CA · contact PI
Protocol Review and Monitoring System$115,865
P30 · FY2023 · CA · contact PI
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer$0
I01 · FY2023 · VA · contact PI
Clinical Protocol and Data Management$133,938
P30 · FY2022 · CA · contact PI
Protocol Review and Monitoring System$115,865
P30 · FY2022 · CA · contact PI
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer$0
I01 · FY2022 · VA · contact PI
Clinical Protocol and Data Management$133,574
P30 · FY2021 · CA · contact PI
Protocol Review and Monitoring System$115,550
P30 · FY2021 · CA · contact PI
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer$0
I01 · FY2021 · VA · contact PI
Clinical Protocol and Data Management$93,589
P30 · FY2020 · CA · contact PI
Protocol Review & Monitoring System (PRMS)$81,346
P30 · FY2020 · CA · contact PI
Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer$0
I01 · FY2020 · VA · contact PI
Clinical Protocol and Data Management$93,589
P30 · FY2019 · CA · contact PI
Protocol Review & Monitoring System (PRMS)$81,346
P30 · FY2019 · CA · contact PI
Clinical Protocol and Data Management$94,228
P30 · FY2018 · CA · contact PI
Protocol Review & Monitoring System (PRMS)$82,170
P30 · FY2018 · CA · contact PI
Clinical Protocol and Data Management$86,154
P30 · FY2017 · CA · contact PI
Protocol Review & Monitoring System (PRMS)$63,011
P30 · FY2017 · CA · contact PI
Clinical Protocol and Data Management$88,259
P30 · FY2016 · CA · contact PI
Protocol Review & Monitoring System (PRMS)$75,641
P30 · FY2016 · CA · contact PI